Bone-metastatic Castration-resistant Prostate Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-02-02
Clinical Trial Update: Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial update evaluating safety and efficacy of KX2-391 in bone-metastatic, castration-resistant prostate cancer has been completed.